Cargando…
Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction
Cancer cachexia is a complex multi-organ syndrome characterized by body weight loss, weakness, muscle atrophy and fat depletion. With a prevalence of 1 million people in Europe and only limited therapeutic options, there is a high medical need for new approaches to treat cachexia. Our latest results...
Autores principales: | Pötgens, Sarah A., Brossel, Hélène, Sboarina, Martina, Catry, Emilie, Cani, Patrice D., Neyrinck, Audrey M., Delzenne, Nathalie M., Bindels, Laure B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098145/ https://www.ncbi.nlm.nih.gov/pubmed/30120320 http://dx.doi.org/10.1038/s41598-018-30569-5 |
Ejemplares similares
-
Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice
por: Pötgens, Sarah A., et al.
Publicado: (2021) -
Inflammation‐induced cholestasis in cancer cachexia
por: Thibaut, Morgane M., et al.
Publicado: (2020) -
Increased gut permeability in cancer cachexia: mechanisms and clinical relevance
por: Bindels, Laure B., et al.
Publicado: (2018) -
The Janus Face of Cereals: Wheat‐Derived Prebiotics Counteract the Detrimental Effect of Gluten on Metabolic Homeostasis in Mice Fed a High‐Fat/High‐Sucrose Diet
por: Olivares, Marta, et al.
Publicado: (2019) -
Chitin–glucan and pomegranate polyphenols improve endothelial dysfunction
por: Neyrinck, Audrey M., et al.
Publicado: (2019)